Bloomberg Anywhere Remote Login Bloomberg Terminal Request a Demo

Bloomberg

Connecting decision makers to a dynamic network of information, people and ideas, Bloomberg quickly and accurately delivers business and financial information, news and insight around the world.

Company

Financial Products

Enterprise Products

Media

Customer Support

  • Americas

    +1 212 318 2000

  • Europe, Middle East, & Africa

    +44 20 7330 7500

  • Asia Pacific

    +65 6212 1000

Communications

Industry Products

Media Services

Follow Us

Benelux Stocks: Dexia, Imtech, KBC Groep Shares Are Active

Updated on

Feb. 15 (Bloomberg) -- The Netherlands’ AEX-Index gained 0.34, or 0.1 percent, to 370.51 in Amsterdam, its second straight advance. Belgium’s Bel20 Index rose 0.2 percent to 2,730.78.

The following were among the most active stocks in Benelux markets today. Symbols are in parentheses.

Dutch Stocks:

Imtech NV (IM NA) dropped 1.5 percent to 27.82 euros, ending two days of gains. The largest Dutch technical-services company reported full-year net income of 140 million euros ($188.8 million), compared with 126 million euros a year earlier.

Belgian Stocks:

Dexia SA (DEXB BB) soared 4.1 percent to 3.24 euros, paring four days of declines. KBC Groep NV (KBC BB) surged 4.5 percent to 31.80 euros, the highest price since Nov. 4. Belgium’s biggest financial-services company followed the Stoxx 600 Banks Index higher after Barclays Plc reported full-year net income that beat analysts’ estimates.

Separately, weekly magazine Euro reported that KBC may sell shares in its Czech unit CSOB AS as soon as the second half of March. The weekly magazine cited an unidentified person familiar with the matter at KBC. Both KBC and CSOB declined to comment on the Euro article.

To contact the reporter on this story: Fred Pals in Amsterdam at fpals@bloomberg.net

To contact the editor responsible for this story: David Merritt at dmerritt1@bloomberg.net

Please upgrade your Browser

Your browser is out-of-date. Please download one of these excellent browsers:

Chrome, Firefox, Safari, Opera or Internet Explorer.